Brown, Lisle/Cummings’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6K Hold
613
– – ﹤0.01% 581
2026
Q1
$13.5K Hold
613
– – ﹤0.01% 525
2025
Q4
$7.23K Hold
613
– – ﹤0.01% 524
2025
Q3
$9.71K Hold
613
– – ﹤0.01% 505
2025
Q2
$7.02K Buy
613
+481
+364% +$5.42K ﹤0.01% 536
2025
Q1
$1.79K Hold
132
– – ﹤0.01% 658
2024
Q4
$2.23K Sell
132
-40
-23% -$778 ﹤0.01% 599
2024
Q3
$3.5K Hold
172
– – ﹤0.01% 542
2024
Q2
$3.88K Hold
172
– – ﹤0.01% 527
2024
Q1
$4.52K Hold
172
– – ﹤0.01% 489
2023
Q4
$5.42K Buy
172
+132
+330% +$3.58K ﹤0.01% 485
2023
Q3
$1.12K Hold
40
– – ﹤0.01% 529
2023
Q2
$1.48K Hold
40
– – ﹤0.01% 526
2023
Q1
$1.2K Hold
40
– – ﹤0.01% 511
2022
Q4
$1.23K Buy
+40
New +$1.2K ﹤0.01% 497
2022
Q2
– Sell
-600
Closed -$18.9K – 482
2022
Q1
$18.9K Hold
600
– – 0.01% 340
2021
Q4
$20.1K Buy
+600
New +$18.7K 0.01% 337

Other funds holding CC

Brown, Lisle/Cummings's CC Position: Q2 2026 in Review

Brown, Lisle/Cummings held its Chemours (CC) position steady in Q2 2026 at 613 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #581.

Brown, Lisle/Cummings first reported a position in CC in Q4 2021 and has held it in 17 quarters since. The position peaked at $20.1K in Q4 2021. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Brown, Lisle/Cummings held 613 shares of Chemours worth $12.6K as of Q2 2026.
  • Brown, Lisle/Cummings left its Chemours share count unchanged in Q2 2026.
  • Chemours made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #581 holding.
  • Brown, Lisle/Cummings first reported a position in Chemours in Q4 2021 and has held it in 17 quarters since.
  • Brown, Lisle/Cummings's Chemours position peaked at $20.1K in Q4 2021.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.